(Q37990559)

26 August 2017

title

Treatment of interstitial lung diseases associated with connective tissue diseases (English)

1 reference

26 August 2017

1 reference

1 reference

Akiko Kobayashi

1

1 reference

26 August 2017

Hiroshi Okamoto

series ordinal

2

1 reference

26 August 2017

language of work or name

English

0 references

publication date

1 March 2012

1 reference

Expert Review of Clinical Pharmacology

26 August 2017

published in

1 reference

26 August 2017

volume

5

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

219-227

1 reference

Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA.

26 August 2017

cites work

1 reference

Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database

21 January 2018

1 reference

Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology

21 January 2018

1 reference

Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD).

21 January 2018

1 reference

Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease

21 January 2018

1 reference

New developments in scleroderma interstitial lung disease

21 January 2018

1 reference

Interstitial lung disease in primary Sjögren syndrome.

21 January 2018

1 reference

21 January 2018

1 reference

Clinical and radiological features of Pneumocystis pneumonia in patients with rheumatoid arthritis, in comparison with methotrexate pneumonitis and Pneumocystis pneumonia in acquired immunodeficiency syndrome: a multicenter study.

21 January 2018

1 reference

Amyopathic dermatomyositis

21 January 2018

1 reference

Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity.

21 January 2018

1 reference

Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease

21 January 2018

1 reference

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

21 January 2018

1 reference

Interstitial pneumonitis complicating rheumatoid arthritis. Sustained remission with azathioprine therapy

21 January 2018

1 reference

Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial

21 January 2018

1 reference

Cyclophosphamide versus placebo in scleroderma lung disease.

21 January 2018

1 reference

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma

21 January 2018

1 reference

Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease

21 January 2018

1 reference

Effect of mycophenolate mofetil on pulmonary function in scleroderma-associated interstitial lung disease.

21 January 2018

1 reference

A randomized unblinded trial of cyclophosphamide versus azathioprine in the treatment of systemic sclerosis

21 January 2018

1 reference

The effect of D-penicillamine on pulmonary findings in systemic sclerosis

21 January 2018

1 reference

High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial

21 January 2018

1 reference

Interstitial lung disease in systemic sclerosis: a simple staging system

21 January 2018

1 reference

Polymyositis/dermatomyositis and interstitial lung disease: a new therapeutic approach with T-cell-specific immunosuppressants

21 January 2018

1 reference

Treatment of antisynthetase-associated interstitial lung disease with tacrolimus

21 January 2018

1 reference

Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis/dermatomyositis

21 January 2018

1 reference

A long-term study of interstitial lung disease in systemic lupus erythematosus

21 January 2018

1 reference

Pulmonary diffusion capacity in patients with systemic lupus erythematosus.

21 January 2018

1 reference

Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab

21 January 2018

1 reference

Critical analysis of rituximab-induced serological changes in connective tissue diseases

21 January 2018

1 reference

Is there a role for B-cell depletion as therapy for scleroderma? A case report and review of the literature.

21 January 2018

1 reference

Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study

21 January 2018

1 reference

B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis

21 January 2018

1 reference

BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis

21 January 2018

1 reference

Endothelin and scleroderma lung disease

21 January 2018

1 reference

Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

Tyrosine kinases in rheumatoid arthritis

21 January 2018

1 reference

Inhibition of NF-kappaB signaling by fasudil as a potential therapeutic strategy for rheumatoid arthritis

21 January 2018

1 reference

Molecular ablation of transforming growth factor beta signaling pathways by tyrosine kinase inhibition: the coming of a promising new era in the treatment of tissue fibrosis

21 January 2018

1 reference

A one-year, phase I/IIa, open-label pilot trial of imatinib mesylate in the treatment of systemic sclerosis-associated active interstitial lung disease

21 January 2018

1 reference

Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis

21 January 2018

1 reference

Molecular targets of rheumatoid arthritis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ECP.12.9

1 reference

26 August 2017

1 reference